Novo Nordisk Cracks Down on Unauthorized Sales of Ozempic and Wegovy.

TL;DR Summary
Novo Nordisk has filed five initial lawsuits against illegal semaglutide compounders and is preparing to file more in the coming days and weeks. The lawsuits aim to stop the sale of compounded products claiming to include semaglutide and will also tackle false advertising and trademark infringement regarding its semaglutide brands Wegovy, Ozempic, and Rybelsus.
Topics:business#false-advertising#healthcare#lawsuits#novo-nordisk#semaglutide#trademark-infringement
- Novo Nordisk sues unauthorized semaglutide compounders, tempers expectations for Wegovy's global rollout Endpoints News
- Ozempic Maker Sues Spas and Clinics Selling Custom-Made Versions The Wall Street Journal
- Novo Nordisk sues clinics allegedly selling copycat versions of Ozempic and Wegovy AOL
- Wegovy maker Novo Nordisk sues spas over counterfeit drugs Yahoo! Voices
- Novo takes action against unlawful sales of Ozempic, Wegovy FiercePharma
- View Full Coverage on Google News
Reading Insights
Total Reads
0
Unique Readers
9
Time Saved
0 min
vs 1 min read
Condensed
47%
101 → 54 words
Want the full story? Read the original article
Read on Endpoints News